ANTIOXIDANT STATUS AND THE IN VITRO EFFECT OF AMYLASE AND LIPASE ENZYMES ON IRAQI PANCREATIC CANCER PATIENTS

Abstract

cancer of the pancreas Pancreatic cancer has been identified as the 11th most prevalent cancer in the world. It is an incurable malignancy and the seventh major cause of cancer deaths globally in industrialized nations. 100 blood samples were obtained from AL-Anbar oncology cancer and the nearby Baghdad Hospital. Two groups were created out of them. The first group consists of 30 pancreatic cancer patients between the ages of 20 and 40, while the second group consists of 30 patients between the ages of 41 and 60, with 20 healthy individuals serving as the control group. Measurements were made to gather biological data to aid in the early diagnosis of the illness. The concentration of Amylase enzyme in the serum of pancreatic cancer patients increased, while the concentration of Lipase enzyme decreased when compared to the control group, according to the results of the measurements of the two groups' levels